Bone as an Endocrine Organ

Cellular Endocrinology in Health and Disease

Volumn , Issue , 2014, Pages 193-205

  Karsenty, Gerard ^a  

^a Department of Medicine   (United States)

Author keywords

Bone; Energy metabolism; Glucose homeostasis; Male fertility; Osteocalcin

Indexed keywords

EID: 84902401761     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-408134-5.00012-3     Document Type: Chapter

References (51)

1. Karsenty G. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 2006, 4:341-348.
2. Rodan G.A., Martin T.J. Therapeutic approaches to bone diseases. Science 2000, 289:1508-1514.
3. Teitelbaum S.L. Osteoclasts, integrins, and osteoporosis. J Bone Miner Metab 2000, 18:344-349.
4. Harada S., Rodan G.A. Control of osteoblast function and regulation of bone mass. Nature 2003, 423:349-355.
5. Reid I.R. Relationships among body mass, its components, and bone. Bone 2002, 31:547-555.
6. Rigotti N.A., Nussbaum S.R., Herzog D.B., Neer R.M. Osteoporosis in women with anorexia nervosa. N Engl J Med 1984, 311:1601-1606.
7. Wolfert A., Mehler P.S. Osteoporosis: prevention and treatment in anorexia nervosa. Eat Weight Disord 2002, 7:72-81.
8. Zhao L.J., Liu Y.J., Liu P.Y., Hamilton J., Recker R.R., Deng H.W. Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 2007, 92:1640-1646.
9. Zipfel S., Seibel M.J., Lowe B., Beumont P.J., Kasperk C., Herzog W. Osteoporosis in eating disorders: a follow-up study of patients with anorexia and bulimia nervosa. J Clin Endocrinol Metab 2001, 86:5227-5233.
10. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000, 100:197-207.
11. Khosla S. Update on estrogens and the skeleton. J Clin Endocrinol Metab 2010, 95:3569-3577.
12. Riggs B.L., O'Fallon W.M., Muhs J., O'Connor M.K., Kumar R., Melton L.J. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 1998, 13:168-174.
13. Kajimura D., Lee H.W., Riley Kyle J., Arteaga-Solis E., Ferron M., Zhou B., et al. Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metabolism 2013, 17(6):901-915.
14. Lee K., Nichols J., Smith A. Identification of a developmentally regulated protein tyrosine phosphatase in embryonic stem cells that is a marker of pluripotential epiblast and early mesoderm. Mech Dev 1996, 59:153-164.
15. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
16. Mauro L.J., Olmsted E.A., Skrobacz B.M., Mourey R.J., Davis A.R., Dixon J.E. Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation. J Biol Chem 1994, 269:30659-30667.
17. Dacquin R., Mee P.J., Kawaguchi J., Olmsted-Davis E.A., Gallagher J.A., et al. Knock-in of nuclear localised β-galactosidase reveals that the tyrosine phosphatase Ptprv is specifically expressed in cells of the bone collar. Dev Dyn 2004, 229:826-834.
18. Ferron M., Hinoi E., Karsenty G., Ducy P. Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008, 105:5266-5270.
19. Hauschka P.V., Lian J.B., Cole D.E., Gundberg C.M. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989, 69:990-1047.
20. Ducy P., Desbois C., Boyce B., Pinero G., Story B., et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996, 382:448-452.
21. Aonuma H., Miyakoshi N., Hongo M., Kasukawa Y., Shimada Y. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption. Tohoku J Exp Med 2009, 218:201-205.
22. Fernandez-Real J.M., Izquierdo M., Ortega F., Gorostiaga E., Gomez-Ambrosi J., et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 2009, 94:237-245.
23. Hwang Y.C., Jeong I.K., Ahn K.J., Chung H.Y. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced β-cell function in middle-aged male subjects. Diabetes Metab Res Rev 2009, 25:768-772.
24. Im J.A., Yu B.P., Jeon J.Y., Kim S.H. Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta 2008, 396:66-69.
25. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Kurioka S., et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009, 94:45-49.
26. Kindblom J.M., Ohlsson C., Ljunggren O., Karlsson M.K., Tivesten A., et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res 2009, 24:785-791.
27. Levinger I., Zebaze R., Jerums G., Hare D.L., Selig S., Seeman E. The effect of acute exercise on undercarboxylated osteocalcin in obese men. Osteoporos Int 2011, 2(5):1621-1666.
28. Pittas A.G., Harris S.S., Eliades M., Stark P., Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009, 94:827-832.
29. Winhofer Y., Handisurya A., Tura A., Bittighofer C., Klein K., et al. Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care 2010, 33:139-143.
30. Yeap B.B., Chubb S.A., Flicker L., McCaul K.A., Ebeling P.R., et al. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol 2010, 163:265-272.
31. Delibegovic M., Bence K.K., Mody N., Hong E.G., Ko H.J., et al. Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B. Mol Cell Biol 2007, 27:7727-7734.
32. Delibegovic M., Zimmer D., Kauffman C., Rak K., Hong E.G., et al. Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes 2009, 58:590-599.
33. Ferron M., Wei J., Yoshizawa T., Del Fattore A., DePinho R.A., et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010, 142:296-308.
34. Saftig P., Hunziker E., Wehmeyer O., Jones S., Boyde A., et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 1998, 95:13453-13458.
35. Scimeca J.C., Franchi A., Trojani C., Parrinello H., Grosgeorge J., et al. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 2000, 26:207-213.
36. Khosla S., Riggs B.L. Pathophysiology of age-related bone loss and osteoporosis. Endocrinol Metab Clin North Am 2005, 34:1015-1030.
37. Khosla S., Melton L.J., Atkinson E.J., O'Fallon W.M. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 2001, 86:3555-3561.
38. Oury F., Sumara G., Sumara O., Ferron M., Chang H., Smith C.E., et al. Endocrine regulation of male fertility by the skeleton. Cell 2011, 144:796-809.
39. Oury F., et al. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest 2013, 123:1-13.
40. Pi M., et al. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PloS One 2008, 3:e3858.
41. Pi M., Quarles L.D. Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks. Endocrinology 2012, 153:2062-2069.
42. Pi M., Wu Y., Quarles L.D. GPRC6A mediates responses to osteocalcin in beta-cells in vitro and pancreas in vivo. J Bone Miner Res 2011, 26:1680-1683.
43. Kumar T.R. Functional analysis of LHbeta knockout mice. Mol Cell Endocrinol 2007, 269:81-84.
44. Burns K.H., Matzuk M.M. Minireview: genetic models for the study of gonadotropin actions. Endocrinology 2002, 143:2823-2835.
45. Saleem U., Mosley T.H., Kullo I.J. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 2010, 30:1474-1478.
46. Kirmani S., et al. Relationship of testosterone and osteocalcin levels during growth. J Bone Miner Res 2011, 26:2212-2216.
47. Fernandez-Real J.M., et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 2009, 94:237-245.
48. Glass A.R., Vigersky R.A. Testicular reserve of testosterone precursors in primary testicular failure. Fertil Steril 1982, 38:92-96.
49. Winters S.J., Troen P. A reexamination of pulsatile luteinizing hormone secretion in primary testicular failure. J Clin Endocrinol Metab 1983, 57:432-435.
50. Kong Y.Y., Boyle W.J., Penninger J.M. Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. Immunol Cell Biol 1999, 77:188-193.
51. Teitelbaum S.L., Ross F.P. Genetic regulation of osteoclast development and function. Nat Rev Genet 2003, 4:638-649.